These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1877399

  • 1. Regulation of de novo and salvage pathways in chemotherapy.
    Weber G, Nagai M, Natsumeda Y, Ichikawa S, Nakamura H, Eble JN, Jayaram HN, Zhen WN, Paulik E, Hoffman R.
    Adv Enzyme Regul; 1991; 31():45-67. PubMed ID: 1877399
    [Abstract] [Full Text] [Related]

  • 2. Targeted and non-targeted actions of anti-cancer drugs.
    Weber G, Prajda N.
    Adv Enzyme Regul; 1994; 34():71-89. PubMed ID: 7942286
    [Abstract] [Full Text] [Related]

  • 3. Critical issues in chemotherapy with tiazofurin.
    Weber G.
    Adv Enzyme Regul; 1989; 29():75-95. PubMed ID: 2699155
    [Abstract] [Full Text] [Related]

  • 4. Tiazofurin: molecular and clinical action.
    Weber G, Prajda N, Abonyi M, Look KY, Tricot G.
    Anticancer Res; 1996; 16(6A):3313-22. PubMed ID: 9042306
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tiazofurin action in leukemia: evidence for down-regulation of oncogenes and synergism with retinoic acid.
    Weber G, Yamaji Y, Nagai M, Natsumeda Y, Jayaram HN, Zhen WN, Paulik E.
    Adv Enzyme Regul; 1990; 30():35-45. PubMed ID: 2206022
    [Abstract] [Full Text] [Related]

  • 7. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot GJ, Jayaram HN, Lapis E, Natsumeda Y, Nichols CR, Kneebone P, Heerema N, Weber G, Hoffman R.
    Cancer Res; 1989 Jul 01; 49(13):3696-701. PubMed ID: 2567208
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Salvage capacity of hepatoma 3924A and action of dipyridamole.
    Weber G, Lui MS, Natsumeda Y, Faderan MA.
    Adv Enzyme Regul; 1983 Jul 01; 21():53-69. PubMed ID: 6443595
    [Abstract] [Full Text] [Related]

  • 14. Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia.
    Weber G, Jayaram HN, Lapis E, Natsumeda Y, Yamada Y, Yamaji Y, Tricot GJ, Hoffman R.
    Adv Enzyme Regul; 1988 Jul 01; 27():405-33. PubMed ID: 2907968
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cell cycle dependent regulation of IMP dehydrogenase activity and effect of tiazofurin.
    Szekeres T, Fritzer M, Pillwein K, Felzmann T, Chiba P.
    Life Sci; 1992 Jul 01; 51(16):1309-15. PubMed ID: 1357518
    [Abstract] [Full Text] [Related]

  • 17. Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin.
    Prajda N, Natsumeda Y, Ikegami T, Reardon MA, Szondy S, Hashimoto Y, Emrani J, Weber G.
    Biochem Pharmacol; 1988 Mar 01; 37(5):875-80. PubMed ID: 3345200
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synergistic action of tiazofurin with hypoxanthine and allopurinol in human neuroectodermal tumor cell lines.
    Szekeres T, Schuchter K, Chiba P, Ressmann G, Lhotka C, Gharehbaghi K, Szalay SM, Pillwein K.
    Biochem Pharmacol; 1993 Dec 03; 46(11):1903-7. PubMed ID: 7903533
    [Abstract] [Full Text] [Related]

  • 20. Targets and markers of selective action of tiazofurin.
    Weber G, Natsumeda Y, Pillwein K.
    Adv Enzyme Regul; 1985 Dec 03; 24():45-65. PubMed ID: 2424286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.